ℹ️
🇬🇧
Search
Search for people relevant for "relapse"
relapse
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Edita Kabíčková Ph.D.
Academic staff at Second Faculty of Medicine
110 publications
Publications
publication
Non-Hodgkin lymphomas in children and adolescents
2013 |
Second Faculty of Medicine
publication
Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "watch and wait" strategy after complete resection
2013 |
Second Faculty of Medicine
publication
Posterior Reversible Encephalopathy Syndrome (PRES) in 5-year-old girl with nephrotic syndrome
2010 |
Second Faculty of Medicine
publication
Treatment of high risk Ewing's sarcoma in children and adolescents. Experience of the Department of Paediatric Oncology, Faculty Hospital Motol
2000 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport, Central Library of Charles University
publication
High-dose chemotherapy in the treatment of malignant lymphoma in children
2000 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
publication
Treatment of Hodgkin's Disease in Children with Vamp (Vinblastine, Adriamycin, Methotrexate, Prednisone) and Vepa (Vinblastine, Etoposide, Prednisone, Adriamycin)
1999 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
publication
Molecular Screening in ALK-Positive Anaplastic Large Cell Lymphoma: ALK Analysis, NGS Fusion Gene Detection, and T-cell Receptor Immunoprofiling
2024 |
Second Faculty of Medicine, Third Faculty of Medicine
publication
Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group
2024 |
Second Faculty of Medicine, Third Faculty of Medicine
publication
Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?
2024 |
Second Faculty of Medicine
publication
Ibrutinib plus RICE/RVICI for R/R mature B-NHL in children/young adults: SPARKLE trial
2023 |
Second Faculty of Medicine
Load more publications (100)
Loading network view...